Analysis of The Financial Performance of PT Kimia Farma, Tbk (Persero) 2021-2022

Authors

  • Nunung Nurbaeti Universitas Terbuka
  • Vella Mirfaqoh Universitas Terbuka
  • Rezki Zulhendra Universitas Terbuka
  • Yosep Hertanto Amin Universitas Terbuka
  • Neo Cahyo Alhadi Universitas Terbuka
  • Ahmad Fadhil Universitas Terbuka
  • Rifi Hamdani Sitohang Universitas Terbuka
  • Sri Yusriani Universitas Terbuka

DOI:

https://doi.org/10.33830/isbest.v3i1.1303

Keywords:

Kimia Farma, financial performance, comparative analysis, ratio analysis, financial reports, net loss, decision-making

Abstract

The effective management of company operations hinges on precise analysis and informed decision-making. Financial reports are pivotal in this decision-making process. In 2022, PT Kimia Farma, Tbk (Persero) registered a net loss, a stark contrast to its performance in 2021. This study aims to assess the financial performance of PT Kimia Farma, Tbk (Persero) during the 2021-2022 period using quantitative descriptive data sourced from financial reports. The employed methodologies include comparative financial statement analysis and financial ratio. Despite the company's robust performance foundation, the findings indicate a decline in its financial performance. The first research on PT Kimia Farma, Tbk (Persero) conducted financial performance during the pandemic or 2020 until 2021. Originality produces financial performance analysis and any suggestions to pharmaceutical companies.

Downloads

Published

2023-11-02

Conference Proceedings Volume

Vol. 3 No. 1 (2023): Proceeding of The 6th International Seminar on Business, Economics, Social Science, and Technology (ISBEST)

Section

Articles

License

Copyright (c) 2023 Nunung Nurbaeti, Vella Mirfaqoh, Rezki Zulhendra, Yosep Hertanto Amin, Neo Cahyo Alhadi, Ahmad Fadhil, Rifi Hamdani Sitohang, Sri Yusriani

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This journal using Creative Common CC BY 4.0